Patents by Inventor Jasper Kaiser

Jasper Kaiser has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11136318
    Abstract: The present disclosure relates to the preparation of methyl 2-(1H-indole-3-carbonyl)thiazole-4-carboxylate (ITE) and related compounds with high yield, purity, and scalability. The processes apply the use of a Weinreb amide intermediate as a scaffold for the preparation of ITE and structural analogs.
    Type: Grant
    Filed: June 19, 2020
    Date of Patent: October 5, 2021
    Assignee: Noramco, LLC
    Inventors: Martin Benedict Strack, Jasper Kaiser, Gnel Mkrtchyan, Wen-Chun Zhang
  • Publication number: 20210009579
    Abstract: The present disclosure relates to the preparation of methyl 2-(1H-indole-3-carbonyl)thiazole-4-carboxylate (ITE) and related compounds with high yield, purity, and scalability. The processes apply the use of a Weinreb amide intermediate as a scaffold for the preparation of ITE and structural analogs.
    Type: Application
    Filed: June 19, 2020
    Publication date: January 14, 2021
    Inventors: Martin Benedict Strack, JASPER KAISER, GNEL MKRTCHYAN, WEN-CHUN ZHANG
  • Patent number: 10544434
    Abstract: The present invention is directed to processes for the preparation of lisdexamfetamine and related derivatives, wherein the processes comprise coupling to racemic or enantiomerically enriched amphetamine and wherein the resulting product is advantageously enantiomerically or diastereomerically enriched in the desired stereoisomer.
    Type: Grant
    Filed: June 15, 2016
    Date of Patent: January 28, 2020
    Assignee: Noramco, Inc.
    Inventors: Pietertje Elisabeth Goudriaan, Jasper Kaiser, Hemen Ibrahim, Govert Arie Verspui, Douglas Phillip Cox
  • Publication number: 20160376618
    Abstract: The present invention is directed to processes for the preparation of lisdexamfetamine and related derivatives, wherein the processes comprise coupling to racemic or enantiomerically enriched amphetamine and wherein the resulting product is advantageously enantiomerically or diastereomerically enriched in the desired stereoisomer.
    Type: Application
    Filed: June 15, 2016
    Publication date: December 29, 2016
    Inventors: Pietertje Elisabeth Goudriaan, Jasper Kaiser, Hemen Ibrahim, Govert Arie Verspui, Douglas Phillip Cox